FDA instability, staff turnover, and evolving review standards are reshaping drug development. Richard Pazdur, formerly with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...

Exceptional track record across multiple clinical development programs for depression, three of which have resulted in regulatory approvalsAppointment strengthens confidence in clinical readiness and ...

The phase 3 D-LIVR study is the largest clinical trial conducted to date in chronic hepatitis D and continues to generate new ...

ST. GALLEN, Switzerland & PALMA, Spain & ZURICH--(BUSINESS WIRE)--Regulatory News: “We are gaining momentum with our ambitious strategic growth plans as we today add Sanifit, Inositec and their ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has entered a manufacturing ...

MALVERN, Pa.--(BUSINESS WIRE)--Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development ...

Royalty Pharma plc has completed a transaction to monetize remaining fixed payments on the MorphoSys Development Funding Bonds for $511 million in cash, resulting in total proceeds of $530 million ...